Octreotide hopefully will prove to significantly reduce liver cysts. Animal proteins seem to increase liver pain, bloating and PLD symptoms. These foods naturally contain growth hormone and some have additional hormones fed to the animals, such as bovine growth hormone, or steroids or estrogen or other hormones. With this latest research paper, of the electron microscope study of liver cysts, if it is possible for one to avoid certain foods this seems best to maintain a minimal of liver cyst growth . Continue to avoid: alcohol, yeast, sugars, concentrated sweets, fat, cream, dairy, milk, cheese, beef, poultry, fried foods, fatty foods, bleach, hormones and caffeine. Some may find this comes about naturally by an aversion to these foods during the recovery phase with a longing for sour, crispy, and truly fresh fruits and vegetables similar to green granny smith apples, crispy greens, sour lemons, grapefruit, and more. Some can taste the metal in canned vegetables served in the hospital food.
Octreotide Clinical Trial The first ever, a clinical trial to see if Sandostatin will diminish liver cysts. This will be completed April 2010.
Octreotide Clinical Trial in Italy. Guiseppe Remuzzi, Mario Negri Institute, Bergamo, Italy: Their study will look at the effect of long-acting somatostatin on disease progression in ADPKD.
Octreotide Clinical Trial in Netherlands. Joost PH Drenth, PhD Radboud University Nijmegen Medical Center.
The Octreotide Clinical Trial will continue into a second phase. This will be continued at the Mayo Clinic in Rochester Minnesota USA.
PHASE I – YEARS 1 & 2
The second phase of the Octreotide study will be open to the original 42 participants who completed phase 1. Phase I is a two year study on octreotide. The first year was blinded; 60% received octreotide; 40% received placebo. I received placebo. The second year of Phase I study all received octreotide. It will be completed the end of March 2010.
PHASE II – YEARS 3 & 4
The second Phase of the octreotide study is underway. Provided is monthly octreotide injectable 28 day for all participants for two full years. The lab work must be covered by participants either through insurance or by self. The cost of once yearly blood work will be around $410. Yearly MRI's will be covered by the study. Participants will need to return to the Mayo at the beginning; in one year and in two year's time. We can fax the 6 month lab work; have it done before we arrive or have it done at the Mayo, whichever is the least expensive for us.
The octreotide trial will no longer check kidney functioning. |